- Mission and Vision
- Our Team
- Clinical Program
- Training, Education, & Fellowship Opportunities
- BSM Mini-Fellowship
- Visiting Philadelphia
- Contact Us
- Support Our Work
- Join Us on Facebook
In the News
Michael Perlis, PhD, is interviewed by WHYY about the role placebo pills may serve in treating patients with insomnia:
From WHYY: "What if you could take half as much of a drug, but still get the full benefit? WHYY's Jessica McDonald reports on early findings at the University of Pennsylvania with sleeping pills that suggests placebos have the potential to dramatically lower dosages." Listen to the full NPR story HERE.
Recent findings on the increased prevalence of completed suicide at night, between 2 and 3am, were presented at the Annual APSS Conference, 2014, by Dr. Michael Perlis. The research team also includes: Drs. Grandner, Gehrman, Dinges, Chakravorty, Basner, Brown, Ross, and Thase. Listen to Dr. Perlis' interview on NPR HERE.
Michael Grandner, PhD, was interviewed about the relationship between sleep, heart health, and our overall health.
TIME reports on a new study from Penn Medicine researchers, led by Michael Grandner, PhD and Jilesh Chheda, research assistant, that found history of marijuana usage, even among quitters, may disrupt a good night's rest. PsychCenteral.com, WebMD, Philadelphia Magazine, Medscape and the UK Daily Mail also reported on the research.
Sheila Garland, PhD, is the lead author of a recent study on the use of CBT-I and mindfulness for the treatment of insomnia in cancer patients.
People who suffer from sleep disturbances are at major risk for obesity, diabetes, and coronary artery disease, according to new research from the Perelman School of Medicine at the University of Pennsylvania, led by Michael A. Grandner, PhD and Philip Gehrman, PhD, CBSM.
Philip Gehrman, PhD, CBSM, clinical director of the Behavioral Sleep Medicine Program spoke about the treatment of insomnia in an interview with ABCNews.com.
Michael Perlis, PhD, associate professor of Psychiatry and director of the Behavioral Sleep Medicine Program, and James Findley, PhD, DABSM, CBSM, senior staff psychologist with the Behavioral Sleep Medicine Program, were featured experts in anABC World News Tonight report on the treatment of insomnia.
Philip Gehrman, PhD, CBSM, clinical director of the Penn Medicine Behavioral Sleep Medicine Program, talks to the Huffington Post about the many strange sleep phenomena that happen in between stages of wake and sleep.
Philip Gehrman, PhD, CBSM, clinical director of Penn Medicine's Behavioral Sleep Medicine program, was interviewed by ABCNews.com about the effects of daylight saving time on sleep.
Philadelphia Magazine spoke with Philip Gehrman, PhD, CBSM, assistant professor of Psychiatry, about Seasonal Affective Disorder remedies.
James Findley, PhD, DABSM, CBSM of the Behavioral Sleep Medicine Program appeared on NBC10's "Wake Up Call".
Philip Gehrman, PhD, CBSM, Clinical Director of the Behavioral Sleep Medicine Program, was interviewed on CBS3's "Talk Philly", regarding insomnia and several ongoing sleep studies.
Click here to view the recruitment commercial video for the Behavioral Sleep Medicine Program
Back to Top